Anupam Rasayan India AAQS
The The AAQS of Anupam Rasayan India (ANURAS.NS) as of Oct 25, 2026 is 3. In the previous year, The AAQS was 3.00 — a change of 0.00% (lower).
Get this data via API
Financial Data API
AAQS
3
YoY
0.00%
Last updated:
Anupam Rasayan India has a current AAQS of 3.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Anupam Rasayan India in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Anupam Rasayan India in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
The Anupam Rasayan India AAQS history
3 Years
10 Years
25 Years
Max
AAQS
Date
AAQS
Jan 1, 2019
3.00 INR
Jan 1, 2020
3.00 INR
Jan 1, 2021
3.00 INR
Jan 1, 2022
3.00 INR
Jan 1, 2023
3.00 INR
Jan 1, 2024
3.00 INR
Jan 1, 2025
3.00 INR
Jan 1, 2026
3.00 INR
| YEAR | AAQS | YoY |
|---|---|---|
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Anupam Rasayan India Stock analysis
What does Anupam Rasayan India do? Anupam Rasayan India Ltd. generates revenue through manufacturing life science related specialty chemicals and other specialty chemicals. The company's Life Science Related Specialty Chemicals segment produces agro intermediates and agro active ingredients for insecticides, fungicides, and herbicides in the agrochemicals industry. It also supplies anti-bacterial and ultraviolet protection intermediates for the personal care industry, and intermediates for active pharmaceutical ingredients in the pharmaceutical segment. The Other Specialty Chemicals segment provides specialty pigments, specialty dyes, and polymer additives for diverse end-user applications. The company sells these products to manufacturers in the agrochemicals, personal care, and pharmaceutical industries, as well as to end-users requiring specialty chemicals for various applications.
The company's product portfolio includes agro intermediates, agro active ingredients, anti-bacterial intermediates, ultraviolet protection intermediates, pharmaceutical intermediates, specialty pigments, specialty dyes, and polymer additives. These products are sold to industrial clients across multiple sectors, including agrochemicals, personal care, and pharmaceuticals. The Life Science Related Specialty Chemicals segment is the primary revenue driver, focusing on high-value chemical products for life science applications. The Other Specialty Chemicals segment supports the company's diversified revenue streams with products used in various industrial applications.
Anupam Rasayan India Ltd. targets manufacturers within the agrochemicals industry for its agrochemical-related products, personal care brands for its personal care intermediates, and pharmaceutical companies for its pharmaceutical intermediates. The company's business model relies on supplying specialized chemical products to these specific industry segments, leveraging its manufacturing capabilities to serve the needs of clients in life science and specialty chemical markets. Anupam Rasayan India is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Anupam Rasayan India stock
The AAQS of Anupam Rasayan India is 3 in 2026.
On Eulerpool you can find the complete historical development of The AAQS Anupam Rasayan India since 2006 – with annual values, charts, and detailed analysis.
The AAQS is a key figure developed by AlleAktien.
The AAQS is a key figure developed by AlleAktien.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Quality — Anupam Rasayan India
All Key Metrics — Anupam Rasayan India
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth